Observational cohort study to evaluate the safety of agomelatine in standard medical practice in depressed patients: a prospective, observational (non interventional), international, multicentre cohort study.

Trial Profile

Observational cohort study to evaluate the safety of agomelatine in standard medical practice in depressed patients: a prospective, observational (non interventional), international, multicentre cohort study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Oct 2017

At a glance

  • Drugs Agomelatine (Primary)
  • Indications Major depressive disorder
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Sep 2016 Interim results (n=625) presented at the 29th Annual Congress of the European College of Neuropsychopharmacology.
    • 01 Dec 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 08 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top